Valuation Pacific Biosciences of California, Inc.
Stocks
PACB
US69404D1081
Advanced Medical Equipment & Technology
|
Market Closed -
Nasdaq
16:00:00 2026-09-09 EDT
|
5-day change | 1st Jan Change | ||
| 1.290 USD | -2.27% |
|
+0.78% | -31.02% |
Company Valuation: Pacific Biosciences of California, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 4,513 | 1,850 | 2,624 | 538.6 | 564.6 | 410.3 | - | - |
| Change | - | -59.02% | 41.85% | -79.47% | 4.82% | -27.33% | - | - |
| Enterprise Value (EV) 1 | 4,365 | 1,974 | 2,884 | 796.2 | 930.4 | 879 | 934.8 | 960.7 |
| Change | - | -54.78% | 46.13% | -72.4% | 16.87% | -5.53% | 6.35% | 2.77% |
| P/E | -23x | -5.84x | -8.11x | -1.63x | -1.03x | -3x | -2.84x | -3.67x |
| PBR | 5.72x | 3.29x | 3.75x | 1.06x | 106x | -4.78x | -2.62x | -2.05x |
| PEG | - | -0.1x | 0.6x | 0.22x | -0x | 0x | -0.52x | 0.2x |
| Capitalization / Revenue | 34.6x | 14.4x | 13.1x | 3.5x | 3.53x | 2.58x | 2.23x | 1.92x |
| EV / Revenue | 33.4x | 15.4x | 14.4x | 5.17x | 5.82x | 5.53x | 5.07x | 4.5x |
| EV / EBITDA | -21.5x | -6.65x | -9.16x | -1.84x | -6.09x | -6.76x | -7.54x | -9.89x |
| EV / EBIT | -20.7x | -6.43x | -8.62x | -1.68x | -1.68x | -6.37x | -6.27x | -7.68x |
| EV / FCF | -37.3x | -7.05x | -10.8x | -3.75x | -8.17x | -6.89x | -10.2x | -16.9x |
| FCF Yield | -2.68% | -14.2% | -9.29% | -26.7% | -12.2% | -14.5% | -9.81% | -5.9% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.89 | -1.4 | -1.21 | -1.12 | -1.82 | -0.44 | -0.464 | -0.36 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 130.5 | 128.3 | 200.5 | 154 | 160 | 158.9 | 184.3 | 213.3 |
| EBITDA 1 | -202.9 | -296.8 | -314.7 | -431.9 | -152.7 | -130 | -123.9 | -97.15 |
| EBIT 1 | -210.4 | -307.2 | -334.5 | -473.1 | -553.9 | -137.9 | -149.1 | -125.1 |
| Net income 1 | -181.2 | -314.2 | -306.7 | -308.7 | -546.4 | -140.6 | -143.1 | -120.2 |
| Net Debt 1 | -148.3 | 124.4 | 260.8 | 257.6 | 365.9 | 468.7 | 524.5 | 550.4 |
| Reference price 2 | 20.460 | 8.180 | 9.810 | 1.830 | 1.870 | 1.320 | 1.320 | 1.320 |
| Nbr of stocks (in thousands) | 220,598 | 226,109 | 267,444 | 294,315 | 301,907 | 310,831 | - | - |
| Announcement Date | 2/15/22 | 2/16/23 | 2/15/24 | 2/13/25 | 2/12/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3x | - | - | - | 410M | |
| 29.97x | 5.32x | 20.4x | 0.31% | 223B | |
| 34.62x | 6.25x | 19.82x | 0.69% | 144B | |
| 37.95x | 9.97x | 21.99x | -.--% | 124B | |
| 16.79x | 3.46x | 11.22x | -.--% | 65.19B | |
| 34.27x | 6.86x | 21.69x | -.--% | 49.99B | |
| 19.37x | 2.33x | 11.69x | 2.63% | 50.49B | |
| 28.6x | 5.65x | 19.18x | 0.7% | 41.4B | |
| 70.54x | 6.74x | 20.53x | -.--% | 39.59B | |
| 42.67x | 6.94x | 24.5x | -.--% | 31.87B | |
| Average | 31.18x | 5.95x | 19.00x | 0.48% | 76.99B | |
| Weighted average by Cap. | 33.11x | 6.15x | 19.39x | 0.43% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- PACB Stock
- Valuation Pacific Biosciences of California, Inc.
Select your edition
All financial news and data tailored to specific country editions
